Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Companies and Investors Gather in San Francisco for J.P. Morgan Healthcare Conference January 8-11

Posted on January 9th, 2018 by in Pharma R&D

Healthcare companies and investors are flocking to San Francisco from January 8-11 for the 36th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel. Continue reading “Companies and Investors Gather in San Francisco for J.P. Morgan Healthcare Conference January 8-11” »

How Pharma Can Make the Most of Gene Tech CRISPR

Posted on December 18th, 2017 by in Pharma R&D

puzzle-2500333_960_720

The gene-editing technology CRISPR, which stands for ‘clustered regularly interspaced short palindromic repeats,’ is one of today’s most-talked-about scientific innovations. In just a few years, it’s gone from being a barely known entity to becoming a regular presence in scientific literature. Continue reading “How Pharma Can Make the Most of Gene Tech CRISPR” »

Pills Have Gone Digital

Posted on November 24th, 2017 by in Pharma R&D

Paranoiacs and conspiracy theorists beware – the digital pill is here. The U.S. Food and Drug Administration announced on November 13 that it had approved Abilify MyCite (aripiprazole tablets with sensors), the first drug in America to have a digital ingestion tracking system. Continue reading “Pills Have Gone Digital” »

As Drug Development Costs Skyrocket, AI Offers Some Hope

Posted on November 20th, 2017 by in Pharma R&D

Last year, researchers from the Tufts Center for the Study of Drug Development published a paper in the Journal of Health Economics that provided an assessment of the current cost for pharmaceutical companies to discover and develop new drugs and biologics. Continue reading “As Drug Development Costs Skyrocket, AI Offers Some Hope” »

  1. 1
  2. 2